ES2149168T3 - Derivados de naftoquinona para el tratamiento de la inflamacion cronica. - Google Patents

Derivados de naftoquinona para el tratamiento de la inflamacion cronica.

Info

Publication number
ES2149168T3
ES2149168T3 ES92903652T ES92903652T ES2149168T3 ES 2149168 T3 ES2149168 T3 ES 2149168T3 ES 92903652 T ES92903652 T ES 92903652T ES 92903652 T ES92903652 T ES 92903652T ES 2149168 T3 ES2149168 T3 ES 2149168T3
Authority
ES
Spain
Prior art keywords
pct
menadione
derivatives
naftoquinone
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92903652T
Other languages
English (en)
Inventor
Joseph Chayen
Lucille Bitensky
George Thomas Baxter Frost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KS Biomedix Ltd
Original Assignee
KS Biomedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919102340A external-priority patent/GB9102340D0/en
Priority claimed from GB919124541A external-priority patent/GB9124541D0/en
Application filed by KS Biomedix Ltd filed Critical KS Biomedix Ltd
Application granted granted Critical
Publication of ES2149168T3 publication Critical patent/ES2149168T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

UN COMPUESTO ACEPTOR DE HIDROGENO, DE REDUCCION-OXIDACION, UTIL PARA EL TRATAMIENTO DE INFLAMACIES, Y QUE ES UN 1,4-DIOXONAFTALENO O 1,4-DIIMINONAFTALENO QUE TIENE BIEN UN ENLACE DOBLE EN LAS POSICIONES 2 Y 3 EN CUYO CASO HAY 2 Y 3 SUSTITUYENTES, O UN ENLACE SENCILLO EN LAS POSICIONES 2 Y 3. EJEMPLOS DE TALES COMPUESTOS SON LOS EPOXIDOS DE MENADIONA Y DERIVADOS DE MENADIONA SOLUBLES EN AGUA TAL COMO EL BISULFITO DE MENADIONA.
ES92903652T 1991-02-04 1992-02-03 Derivados de naftoquinona para el tratamiento de la inflamacion cronica. Expired - Lifetime ES2149168T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919102340A GB9102340D0 (en) 1991-02-04 1991-02-04 Therapeutic compounds
GB919124541A GB9124541D0 (en) 1991-11-19 1991-11-19 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ES2149168T3 true ES2149168T3 (es) 2000-11-01

Family

ID=26298390

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92903652T Expired - Lifetime ES2149168T3 (es) 1991-02-04 1992-02-03 Derivados de naftoquinona para el tratamiento de la inflamacion cronica.

Country Status (10)

Country Link
US (1) US5763479A (es)
EP (1) EP0570414B1 (es)
JP (1) JP3251582B2 (es)
AT (1) ATE194283T1 (es)
AU (1) AU1195092A (es)
DE (1) DE69231222T2 (es)
DK (1) DK0570414T3 (es)
ES (1) ES2149168T3 (es)
GR (1) GR3034445T3 (es)
WO (1) WO1992013532A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2149633C1 (ru) * 1999-09-01 2000-05-27 Хачатрян Ашот Папикович Способ лечения иммунодефицитных состояний организма
CA2401340A1 (en) * 2000-02-28 2001-09-07 The University Of British Columbia Compositions and methods for the treatment of inflammatory disease using topoisomerase inhibitors
GB0104571D0 (en) * 2001-02-23 2001-04-11 Ks Biomedix Holdings Plc Composition
GB0117326D0 (en) * 2001-07-16 2001-09-05 Univ Aberdeen Napthoquinone-type inhibitors of protein aggregation
CA2504334A1 (en) * 2002-10-30 2004-05-21 Galileo Pharmaceuticals, Inc. Identifying therapeutic compounds based on their physical-chemical properties
ITMI20031011A1 (it) * 2003-05-20 2004-11-21 Vanetta S P A Composti biocidi per il trattamento delle acque.
EP1791517B1 (de) * 2004-09-06 2011-08-10 Schwan-STABILO Cosmetics GmbH & Co. KG Zubereitung, insbesondere kosmetische zubereitung, verfahren zu ihrer herstellung und ihre verwendung
KR100769708B1 (ko) 2006-09-21 2007-10-23 한국생명공학연구원 살충활성을 갖는 설포닐 나프토퀴논류 화합물들의유기합성방법과 살충제 이용 기술

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2367302A (en) * 1940-03-25 1945-01-16 Abbott Lab Bisulphite derivatives of 2-methyl-1, 4-naphthoquinone and the like
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung

Also Published As

Publication number Publication date
US5763479A (en) 1998-06-09
DE69231222D1 (de) 2000-08-10
WO1992013532A2 (en) 1992-08-20
AU1195092A (en) 1992-09-07
DE69231222T2 (de) 2001-03-01
JP3251582B2 (ja) 2002-01-28
EP0570414A1 (en) 1993-11-24
EP0570414B1 (en) 2000-07-05
DK0570414T3 (da) 2000-11-06
ATE194283T1 (de) 2000-07-15
JPH06505005A (ja) 1994-06-09
WO1992013532A3 (en) 1992-10-29
GR3034445T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
ES2091467T3 (es) Composicion y metodo para mejorar el bronceado solar.
BR8906719A (pt) Composicoes microbiocidas sinergisticas,contendo 2-n-octil-isotiazolona e certos biocidas comerciais
ES2159309T3 (es) Semillas tratadas.
AR020020A1 (es) Composicion para el tratamiento de cancer y metodo usando moduladores de transduccion de senal y aceites esenciales de plantas naturales como sinergistas para tratamientos convencionales
MX9307185A (es) Derivados de carboxilato de indol que inhiben la biosintesis del leucotrieno y composiciones farmaceuticas que los contienen.
PT885098E (pt) Agente de proteccao da madeira para trabalhos de manutencao
CO4290359A1 (es) Metodo para tratar la alopecia androgenica con inhibidores 5-alfa-reductasa
ES2156120T3 (es) Derivados arilamidicos.
MX9202132A (es) Imidazobenzoquinonas y composicion que las contienen para prevenir o tratar la hipertension o el fallo cardiaco congestivo.
MX9203643A (es) Derivados imidociclicos y procedimiento para su preparacion.
ES2149168T3 (es) Derivados de naftoquinona para el tratamiento de la inflamacion cronica.
NO984330D0 (no) Benzopyranderivater som har leukotrien-antagonistisk virkning
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
ATE30583T1 (de) Vitamin-d3-derivate.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
ES2066546T3 (es) Composicion farmaceutica para inhibir la resorcion osea.
IT1247796B (it) Derivati arilvinilamidici e procedimento per la loro preparazione
ES2078904T3 (es) Nuevos derivados de neplanocina.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2053039T3 (es) Procedimiento para impedir el cambio de color de los alimentos.
ES2191211T3 (es) Uso de acido peracetico en piscicultura.
ATE147628T1 (de) Iloprost mit wirkung gegen cerebrale malaria
ES2158887T3 (es) Procedimiento para tratar la prostatitis cronica con 17 beta-n-terc-butilcarbamoil-4-aza-5 alfa-androst-1-en-ona.
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
DE60126591D1 (de) In-vitro-Verwendung von Astaxanthin zur Vorbehandlung von Zellen vor UV-Bestrahlung zwecks Hemmung der Aktivierung von NF-KB

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19960517

FG2A Definitive protection

Ref document number: 570414

Country of ref document: ES